Showing results (1-10 of 1,996) with videos related to
Sort By:
Pageof 200
Bulletin Du Cancer|February 5, 1999
[Irinotecan pharmacokinetics]G G Chabot, J Robert, F Lokiec, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trialsL P Rivory, M C Haaz, P Canal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Ifosfamide: pharmacokinetic properties for central nervous system metastasis preventionF LokiecBulletin Du Cancer|May 26, 1999
[Usefulness of a pharmacokinetic approach for clinical antineoplastic chemotherapy evaluation]F LokiecCancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of irinotecan and its metabolites in human blood, bile, and urineF Lokiec, P Canal, C Gay, et al.Pathology Oncology Research : POR|October 8, 1998
Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapyP Canal, E Gamelin, G Vassal, et al.Journal of Pediatric Orthopedics. Part B|November 12, 1998
Simple bone cyst: etiology, classification, pathology, and treatment modalitiesF Lokiec, S WientroubLa Nouvelle Presse Medicale|October 18, 1980
[Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)]F Lokiec, Y NajeanAnticancer Research|November 1, 1994
Factors involved in clinical pharmacology variability in oncology (review)G G ChabotPageof 200